Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 858293, 11 pages
http://dx.doi.org/10.1155/2014/858293
Review Article

Functional Stability of Plasminogen Activator Inhibitor-1

1Department of Bioengineering, Marmara University, 34722 Istanbul, Turkey
2Department of Cardiology, Faculty of Medicine, Marmara University, Selimiye M. Tibbiye C. No. 38, Haydarpasa, 34668 Istanbul, Turkey

Received 30 July 2014; Accepted 17 September 2014; Published 15 October 2014

Academic Editor: Nejat Akar

Copyright © 2014 Songul Yasar Yildiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [31 citations]

The following is the list of published articles that have cited the current article.

  • Manal Zahran, Fatma Mohammed Nasr, Amna Ahmed Metwaly, Noha El-Sheikh, Nevine Sherif Ali Khalil, and Tarek Harba, “The Role of Hemostatic Factors in Atherosclerosis in Patients with Chronic Renal Disease.,” Electronic physician, vol. 7, no. 5, pp. 1270–6, 2015. View at Publisher · View at Google Scholar
  • Honari Pooyan, Ebrahimi Ahmad, and Rakhshan Azadeh, “4G/5G and A-844G polymorphisms of plasminogen activator inhibitor-1 associated with glioblastoma in Iran - A case-control study,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 15, pp. 6327–6330, 2015. View at Publisher · View at Google Scholar
  • Guangping Zhang, Hong Yang, Tonghui Ma, Tingting Han, Dong Yan, and Zuguang Ye, “Modulation of plasminogen activator inhibitor-1 (PAI-1) by the naphthoquinone shikonin,” Fitoterapia, vol. 113, pp. 117–122, 2016. View at Publisher · View at Google Scholar
  • J. L. Eddy, J. A. Schroeder, D. L. Zimbler, A. J. Caulfield, and W. W. Lathem, “ Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulence ,” Journal of Thrombosis and Haemostasis, 2016. View at Publisher · View at Google Scholar
  • C. Savoy, R. J. Van Lieshout, and M. Steiner, “Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?,” Acta Physiologica, 2016. View at Publisher · View at Google Scholar
  • Maria D. Salazar Garcia, Nayoung Sung, Thomas M. Mullenix, Svetlana Dambaeva, Kenneth Beaman, Alice Gilman-Sachs, and Joanne Kwak-Kim, “Plasminogen Activator Inhibitor-1 4G/5G Polymorphism is Associated with Reproductive Failure: Metabolic, Hormonal, and Immune Profiles,” American Journal of Reproductive Immunology, 2016. View at Publisher · View at Google Scholar
  • Deborah Cristina Landi Masquio, Aline de Piano-Ganen, Lila Missae Oyama, Raquel Munhoz da Silveira Campos, Aline Boveto Santamarina, Gabriel Inácio de Morais Honorato de Souza, Aline Dal’Olio Gomes, Renata Guimarães Moreira, Flávia Campos Corgosinho, Claudia Maria Oller do Nascimento, Lian Tock, Sergio Tufik, Marco Túlio de Mello, and Ana R. Dâmaso, “The role of free fatty acids in the inflammatory and cardiometabolic profile in adolescents with metabolic syndrome engaged in interdisciplinary therapy,” The Journal of Nutritional Biochemistry, 2016. View at Publisher · View at Google Scholar
  • Yan Yang, and Hong Tang, “Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia,” Cellular & Molecular Immunology, 2016. View at Publisher · View at Google Scholar
  • Mao Luo, Rong Li, Meiping Ren, Ni Chen, Xin Deng, Xiaoyong Tan, Yongjie Li, Min Zeng, Yan Yang, Qin Wan, and Jianbo Wu, “Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets,” Scientific Reports, vol. 6, pp. 36687, 2016. View at Publisher · View at Google Scholar
  • Yan Xu, Shilei Guo, Cui Wei, Honglan Li, Lei Chen, Chang Yin, and Chuansen Zhang, “The Comparison of Adipose Stem Cell and Placental Stem Cell in Secretion Characteristics and in Facial Antiaging,” Stem Cells International, vol. 2016, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • A. Bukowska, M. Felgendreher, B. Scholz, C. Wolke, J.S. Schulte, E. Fehrmann, E. Wardelmann, M.D. Seidl, U. Lendeckel, K. Himmler, A. Gardemann, A. Goette, and F.U. Müller, “CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis,” Thrombosis Research, 2017. View at Publisher · View at Google Scholar
  • Turid Frahnow, Andreas Friedrich Hermann Pfeiffer, Ina Bergheim, Anna Janina Engstler, and Michael Kruse, “Plasminogen Activator Inhibitor-1 is Regulated Through Dietary Fat Intake and Heritability: Studies in Twins,” Twin Research and Human Genetics, vol. 20, no. 4, pp. 338–348, 2017. View at Publisher · View at Google Scholar
  • Bo Yu, Guangping Zhang, Lingling Jin, Bo Zhang, Dong Yan, Hong Yang, Zuguang Ye, and Tonghui Ma, “Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Yunlun Li, Xinya Zhang, Wenqing Yang, Chao Li, Yanjun Chu, Haiqiang Jiang, and Zhenzhen Shen, “Mechanism of the protective effects of the combined treatment with rhynchophylla total alkaloids and sinapine thiocyanate against a prothrombotic state caused by vascular endothelial cell inflammatory damage,” Experimental and Therapeutic Medicine, vol. 13, no. 6, pp. 3081–3088, 2017. View at Publisher · View at Google Scholar
  • Mehmet Agirbasli, Fatih Göktay, Irem Peker, Pembegul Gunes, Fugen Vardar Aker, and Mustafa Akkiprik, “Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions,” Cardiovascular Therapeutics, vol. 35, no. 3, pp. e12255, 2017. View at Publisher · View at Google Scholar
  • Deniz Agirbasli, and Mehmet Agirbasli, “Plasminogen Activator Inhibitor-1,” Encyclopedia of Signaling Molecules, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Deniz Agirbasli, and Mehmet Agirbasli, “Plasminogen Activator Inhibitor-1,” Encyclopedia of Signaling Molecules, pp. 4055–4063, 2017. View at Publisher · View at Google Scholar
  • Kiyoshi Iida, Shigemasa Tani, Wataru Atsumi, Tsukasa Yagi, Kenji Kawauchi, Naoya Matsumoto, and Atsushi Hirayama, “Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder,” Coronary Artery Disease, vol. 28, no. 7, pp. 577–587, 2017. View at Publisher · View at Google Scholar
  • Yan Jiang, Xiaoli Chen, and Dianling Pan, “miR-30c may serve a role in endometriosis by targeting plasminogen activator inhibitor-1,” Experimental and Therapeutic Medicine, vol. 14, no. 5, pp. 4846–4852, 2017. View at Publisher · View at Google Scholar
  • Jelena Milenkovic, Maja Milojkovic, Tatjana Jevtovic Stoimenov, Boris Djindjic, and Edita Miljkovic, “Mechanisms of plasminogen activator inhibitor 1 action in stromal remodeling and related diseases,” Biomedical Papers, 2017. View at Publisher · View at Google Scholar
  • Klimentova, Voronin, Suchkov, Ryabkov, Kalinin, Isakov, and Mzhavanadze, “Impact of intrinsic coagulation pathway factors activity and hemostatic markers of endothelial dysfunction on thrombotic complications in patients with atherosclerotic peripheral arterial disease,” Novosti Khirurgii, vol. 25, no. 6, pp. 643–654, 2017. View at Publisher · View at Google Scholar
  • Francesco Angelini, Francesca Pagano, Antonella Bordin, Vittorio Picchio, Elena De Falco, and Isotta Chimenti, “Getting Old through the Blood: Circulating Molecules in Aging and Senescence of Cardiovascular Regenerative Cells,” Frontiers in Cardiovascular Medicine, vol. 4, 2017. View at Publisher · View at Google Scholar
  • Tatjana Bošković Matić, Aleksandar Gavrilović, Snežana Simović, Dejan Aleksić, Katarina Vesić, Ana Azanjac, Slavčo Tončev, and Svetlana Miletić Drakulić, “Specific Polymorphism 4G/5G Gene for PAI-1 As a Possible Cause of Cerebral Venous Thrombosis: A Case Report,” Serbian Journal of Experimental and Clinical Research, no. 0, 2017. View at Publisher · View at Google Scholar
  • Yutaka Yatomi, Masako Nishikawa, Katsumi Miyauchi, Tomo Shimizu, Junken Aoki, Chiharu Takahashi, Makoto Kurano, Kuniyuki Kano, Tomotaka Dohi, and Hiroyuki Daida, “Vehicle-dependent effects of sphingosine 1-phosphate on plasminogen activator inhibitor-1 expression,” Journal of Atherosclerosis and Thrombosis, vol. 24, no. 9, pp. 954–969, 2017. View at Publisher · View at Google Scholar
  • Yu Jiang, Guangping Zhang, Dong Yan, Hong Yang, Zuguang Ye, and Tonghui Ma, “Bioactivity-Guided Fractionation of the Traditional Chinese Medicine Resina Draconis Reveals Loureirin B as a PAI-1 Inhibitor,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • J. L. Saes, S. E. M. Schols, W. L. van Heerde, and M. R. Nijziel, “Hemorrhagic disorders of fibrinolysis: a clinical review,” Journal of Thrombosis and Haemostasis, 2018. View at Publisher · View at Google Scholar
  • M. Latha, M. Muthulakshmi, and G. Kavitha, “Detection of Schizophrenia Disorder from Ventricle Region in MR Brain Images via Hu Moment Invariants Using Random Forest,” Advanced Computational and Communication Paradigms, vol. 475, pp. 213–223, 2018. View at Publisher · View at Google Scholar
  • Saeede Karbasforush, Alireza Nourazarian, Masoud Darabi, Reza Rahbarghazi, Fatemeh Khaki-Khatibi, Çıgır Biray Avci, Leila Salimi, Bakiye Goker Bagca, Tanaz Novin Bahador, Aysa Rezabakhsh, and Majid Khaksar, “Docosahexaenoic acid reversed atherosclerotic changes in human endothelial cells induced by palmitic acid in vitro,” Cell Biochemistry and Function, 2018. View at Publisher · View at Google Scholar
  • Jelena Milenković, Edita Miljković, Katarina Milenković, and Novica Bojanić, “Plasminogen Activator Inhibitor 1 (Pai - 1) As A Potential Diagnostic And Therapeutic Target,” Acta Medica Medianae, vol. 57, no. 2, pp. 106–112, 2018. View at Publisher · View at Google Scholar
  • Piotr Rhone, Barbara Ruszkowska-Ciastek, Kornel Bielawski, Alen Brkic, Elżbieta Zarychta, Barbara Góralczyk, Krzysztof Roszkowski, and Danuta Rość, “Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients,” Bioscience Reports, vol. 38, no. 2, pp. BSR20171657, 2018. View at Publisher · View at Google Scholar
  • M. M. Tanashyan, O. V. Lagoda, A. N. Evdokimenko, A. A. Shabalina, and A. A. Raskurazhev, “Cerebral atherosclerosis: a biomarker profile,” Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, vol. 118, no. 5, pp. 23, 2018. View at Publisher · View at Google Scholar